BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 10789883)

  • 1. Acute exposure to saccharin reduces morphine analgesia in the the rat: evidence for involvement of N-methyl-D-aspartate and peripheral opioid receptors.
    McNally GP; Westbrook RF
    Psychopharmacology (Berl); 2000 Mar; 149(1):56-62. PubMed ID: 10789883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.
    Juni A; Klein G; Kest B
    Brain Res; 2006 Jan; 1070(1):35-44. PubMed ID: 16409995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of morphine analgesia by LPS: role of opioid and NMDA receptors and spinal glia.
    Johnston IN; Westbrook RF
    Behav Brain Res; 2005 Jan; 156(1):75-83. PubMed ID: 15474652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of systemic, intracerebral, or intrathecal administration of an N-methyl-D-aspartate receptor antagonist on associative morphine analgesic tolerance and hyperalgesia in rats.
    McNally GP; Westbrook RF
    Behav Neurosci; 1998 Aug; 112(4):966-78. PubMed ID: 9733203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
    Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
    Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. μ-Opioid and N-methyl-D-aspartate receptors in the amygdala contribute to minocycline-induced potentiation of morphine analgesia in rats.
    Ghazvini H; Rezayof A; Ghasemzadeh Z; Zarrindast MR
    Behav Pharmacol; 2015 Jun; 26(4):383-92. PubMed ID: 25563202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of NMDA receptor antagonists on acute mu-opioid analgesia in the rat.
    Redwine KE; Trujillo KA
    Pharmacol Biochem Behav; 2003 Sep; 76(2):361-72. PubMed ID: 14592689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
    Feng J; Kendig JJ
    Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for opiate-activated NMDA processes masking opiate analgesia in rats.
    Célèrier E; Laulin J; Larcher A; Le Moal M; Simonnet G
    Brain Res; 1999 Nov; 847(1):18-25. PubMed ID: 10564731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical opioids in mice: analgesia and reversal of tolerance by a topical N-methyl-D-aspartate antagonist.
    Kolesnikov Y; Pasternak GW
    J Pharmacol Exp Ther; 1999 Jul; 290(1):247-52. PubMed ID: 10381783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinociceptive potentiation and attenuation of tolerance by intrathecal co-infusion of magnesium sulfate and morphine in rats.
    McCarthy RJ; Kroin JS; Tuman KJ; Penn RD; Ivankovich AD
    Anesth Analg; 1998 Apr; 86(4):830-6. PubMed ID: 9539610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of NMDA, opioid and dopamine D1 and D2 receptor signaling in the acquisition of a quinine-conditioned flavor avoidance in rats.
    Rotella FM; Badalia A; Duenas SM; Hossain M; Saeed S; Touzani K; Sclafani A; Bodnar RJ
    Physiol Behav; 2014 Apr; 128():133-40. PubMed ID: 24508751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of the number of NMDA receptors in the development of supersensitivity or tolerance to and dependence on morphine.
    Koyuncuoglu H; Nurten A; Yamantürk P; Nurten R
    Pharmacol Res; 1999 Apr; 39(4):311-9. PubMed ID: 10208762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of acute or repeated restraint stress on morphine-induced locomotion: involvement of dopamine, opioid and glutamate receptors.
    del Rosario CN; Pacchioni AM; Cancela LM
    Behav Brain Res; 2002 Aug; 134(1-2):229-38. PubMed ID: 12191809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of N-methyl-D-aspartate receptors and nitric oxide in the rostral ventromedial medulla in modulating morphine pain-inhibitory signals from the periaqueductal grey matter in rats.
    Javanmardi K; Parviz M; Sadr SS; Keshavarz M; Minaii B; Dehpour AR
    Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):585-9. PubMed ID: 16026519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of peripheral opioid receptors by methylnaltrexone does not prevent morphine tolerance in rats.
    Blomqvist KJ; Dudek KA; Viisanen H; Mätlik K; Ahlström FHG; Laitila J; Kalso EA; Rauhala PV; Lilius TO
    J Neurosci Res; 2022 Jan; 100(1):329-338. PubMed ID: 32459013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal high-dose morphine induces spinally-mediated behavioral responses through NMDA receptors.
    Sakurada T; Watanabe C; Okuda K; Sugiyama A; Moriyama T; Sakurada C; Tan-No K; Sakurada S
    Brain Res Mol Brain Res; 2002 Jan; 98(1-2):111-8. PubMed ID: 11834301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nociception increases during opioid infusion in opioid receptor triple knock-out mice.
    Juni A; Klein G; Pintar JE; Kest B
    Neuroscience; 2007 Jun; 147(2):439-44. PubMed ID: 17544222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists.
    Abul-Husn NS; Sutak M; Milne B; Jhamandas K
    Br J Pharmacol; 2007 Jul; 151(6):877-87. PubMed ID: 17502848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.